1. Introduction {#sec1}
===============

*Panax ginseng* Meyer (Araliaceae) is a precious botanical drug that has been used as a general tonic in eastern countries for more than two thousand years. It is famous for the efficacy in reinforcing vital energy, invigorating spleen for benefiting the lung, and recuperating from diseases. Ginseng saponins (ginsenosides), the major biologically active components of *P. ginseng*, were contributed to its various pharmacological effects and have been administrated to treat cancer [@bib1], [@bib2], diabetes [@bib3], cardiovascular disorders [@bib4], aging [@bib5], and so on. Based on the diverse structure differentiation of the sapogenins, the known ginsenosides can be further classified into six different subtypes: the protopanaxadiol (PPD) type, protopanaxatriol type, octillol type, oleanolic acid type, C17 side chain--varied type, and miscellaneous triterpenes. The PPD, protopanaxatriol, oleanolic acid, and octillol types are the four most common subtypes among the saponins from ginseng plant [@bib6], [@bib7].

Recent studies have been focusing on the synthesis of more active PPD derivatives from dammarane-type triterpene saponins, conversion products using artificial gastric juice, acidic and alkaline hydrolysis from total ginseng saponins, and extraction of malonylginsenosides under room temperature. The new products obtained have showed promising antidiabetic and antitumor properties [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13]. Researchers never stop to report new compounds related to ginsenosides [@bib14], [@bib15]. In view of the wide range of potent activities, ginseng (ginsenosides) can be regarded as the source of active lead compounds research.

Owing to our continued interests in the chemical diversity and structure--bioactivity relationship of ginsenosides [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], we investigated the flower buds of *P. ginseng* and obtained 6 new ginsenosides, **1**, **2**, **6--8**, and **10**, and 4 known ginsenosides. Herein, we report the isolation and structure elucidation of these new ginsenosides, along with their antiproliferative activities against three human cancer cell lines (HL-60, MGC80-3, and Hep-G2).

2. Materials and methods {#sec2}
========================

2.1. Plant materials {#sec2.1}
--------------------

The flower buds of *P. ginseng* were collected in Tonghua city, Jilin province of China in July 2014 and identified by one of the authors (Xiao-Jie Gong). A voucher specimen (No.2014003) of this plant was deposited at our laboratory.

2.2. Apparatus and chemicals {#sec2.2}
----------------------------

Optical rotation values were measured using a P--2000 digital polarimeter (Jasco, Tokyo, Japan). IR spectra were recorded on a Nicolet 550 FT--IR spectrophotometer (Nicolet Instrument. Inc., Madison, USA) using KBr pellets. NMR spectra were measured uisng a DRX 500 MHz NMR spectrometer (Bruker Corporation, Bremen, Germany) using trimethylsilane as the internal standard. The high-resolution LC--MS spectra were recorded using a QTOF 6540 mass spectrometer (Agilent Technologies, Waldbronn, Germany) and LC--MS--2010EV mass spectrometer (Shimadzu Corporation, Kyoto, Japan). Column chromatography (CC) was performed on silica gel (200--400 mesh, Qingdao Marine Chemical co., Ltd, Qingdao, China), Diaion HP-20 (Mitsubishi Chemical Corporation, Tokyo, Japan) and MCI gel (75--150 μm, Chengdu Kepubio Co., Ltd, Chengdu, China). TLC was carried out on a precoated silica gel plate High-efficiency Silica Gel (HSG) F~254~ (0.25 mm, Qingdao Marine Chemical Co., Ltd, Qingdao, China); spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. The semi-preparative HPLC was performed on a Beijing CXTH LC--3000 system (Beijing Chuang Xin Tong Heng Science Technology Co. Ltd., Beijing, China) coupled with Daisogel C~18~ column (5 μm, 250 × 30 mm; Cherish Technology Co., Ltd, Beijing, China), and all UV detection was set at 203 nm with a flow rate of 5 mL/min. The sugar determinations were conducted using a 1200 HPLC system (Agilent Technologies) using a Kaseisorb LC NH~2~--60--5 column (5 μm, 250 × 4.6 mm; Kasei Kogyo Co. Ltd, Tokyo, Japan). Analytical-grade reagents of *n*-hexane, ethyl acetate (EtOAc), chloroform (CHCl~3~), ethanol (EtOH), and methanol (MeOH) were purchased from Kemiou Pure Chemical Co. Ltd. (Tianjin, China). HPLC-grade acetonitrile (MeCN) and MeOH were obtained from Sigma--Aldrich Chemical Co. (St. Louis, USA). Deionized water was purified using a Milli--Q system (Billerica, USA) in our laboratory.

The human cancer cell lines, HL-60, MCF-7 and Hep-G2, were obtained from the Cell Resource Center, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/Peking Union Medical College (Beijing, China). The cell lines were cultured in an MCO-15 AC carbon dioxide (CO~2~) incubator (Sanyo, Osaka, Japan). Dimethyl sulfoxide and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H- tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Co. (St. Louis, USA). Ninety-six--well plates (Corning Costar) were purchased from Corning Inc. (Cambridge, USA). Nonessential amino acids, fetal bovine serum, Roswell Park Memorial Institute (RPMI) 1640 medium, and Dulbecco\'s modified Eagle\'s medium were purchased from Gibcol Laboratories (Grand Island, USA). Penicillin--streptomycin solution was purchased from Corning CellGro (Manassas, USA). Vinorelbine was purchased from Jianglaibio Co. Ltd. (Shanghai, China).

2.3. Extraction and isolation {#sec2.3}
-----------------------------

The extraction of *P. ginseng* flower buds (4.1 kg) was performed with 70% EtOH (3 × 16 L) under reflux. The extract was concentrated on a rotary evaporator to give a dark brown residue (892 g), and then the residue was dissolved in H~2~O (4 L) and subjected to liquid−liquid partitioning using *n*−hexane (3 × 12 L) and EtOAc (3 × 12 L) to provide the *n*-hexane (200 g), EtOAc (31 g), and water-soluble (645 g) fractions. The EtOAc fraction was separated on silica gel and eluted with CHCl~3~/MeOH/H~2~O (gradient, 100:10:1 to 10:10:1) to yield fractions E1--E9. Fraction E5 (2.8 g) was chromatographed on an MCI gel column using 75% EtOH to yield 6 subfractions E5A--E5F, and the subfraction E5E (62 mg) was purified by semipreparative HPLC with 80% MeOH to afford **1** (11.4 mg). Similarly, Fraction E6 (900 mg) was separated by 80% EtOH to yield 5 subfractions E6A--E6E, and the subfraction E6D (41 mg) was purified with 75% MeOH to afford **2** (10.2 mg). Fraction E7 (4.8 g) was separated by a gradient of EtOH-H~2~O (60% to 100%), and **3** (524 mg) was afforded with 80% EtOH. The water fraction (200 g) was further fractionated on a Diaion HP-20 resin column, eluting with EtOH/H~2~O (gradient, 0:100 to 100:0) to yield 5 fractions W1-W5. Fraction W3 (26 g) was separated on an MCI gel column eluting with EtOH/H~2~O (gradient, 40:60 to 100:0), producing 11 subfractions W3A--W3K. And, the subfraction W3B (6 g) was separated by MCI gel column eluting with 70% EtOH, giving two subfractions W3B-1 and W3B-2. Semipreparative HPLC was used to purify subfraction W3B-2 (911 mg) to obtain **4** (25.4 mg) and **5** (661 mg). Subfraction W3D (3.2 g) was separated by combining silica gel (CHCl~3~/MeOH/H~2~O 6:1:0.1 to 2:1:0.1) and MCI gel (75% EtOH) column. After the MCI gel fractionation, four (subfraction W3D-1 to subfraction W3D-4) subfractions were obtained. Subfraction W3D-2 (77 mg) and W3D-4 (43 mg) were all further purified by semipreparative HPLC with 35% MeCN to afford **6** (8.6 mg), **7** (9.2 mg), and **8** (7.5 mg). Subfraction W3H (1.4 g) was separated by silica gel (CHCl~3~/MeOH/H~2~O 5:1:0.1) repeatedly to afford **9** (282 mg). Fraction W4 (21 g) was separated by MCI gel column eluting with 80% EtOH, giving 6 subfractions W4A--W4F. Further purification of subfraction W4D (92 mg) by semipreparative HPLC with 35% MeCN afforded **10** (12.5 mg).

2.4. Acid hydrolysis of new compounds {#sec2.4}
-------------------------------------

The acid hydrolysis of new compounds and sugar determination were based on our previously reported method by HPLC analysis [@bib16]. All the glucose residues from those 6 new compounds showed the retention time of 12.6 min, which was the same as [d]{.smallcaps}-glucose [@bib16]. In addition, the rhamnosyl moiety in **6** and the arabinosyl moiety in **6** and **7** were ~L~-configured (*t*~R~ 9.6 and 10.7 min, respectively) [@bib16], [@bib22], and the xylosyl moiety in **7** was [d]{.smallcaps}-configured (*t*~R~ 9.2 min) [@bib22], showing that the retention times were consistent with those of the authentic samples.

2.5. Cytotoxicity assay {#sec2.5}
-----------------------

HL-60 and MGC80-3 cells were cultured in RPMI 1640 medium, and Hep-G2 cells were cultured in Dulbecco\'s modified Eagle\'s medium, supplemented with 10% fetal bovine serum, 100 unit/mL penicillin plus 100 μg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO~2~. The cytotoxicity assay was detected by MTT method [@bib23]. MCF-7, Hep-G2, and HL-60 cells were seeded into 96-well plates in a density of 2 × 10^4^, 1 × 10^4^, and 0.5 × 10^4^ cells/well in 100 μL, respectively. After 24 h of incubation at 37°C, test compounds at various concentrations (1, 10, 50, 100, 150, and 200 μM) were added and incubated for 48 h. Continuously, each well was treated with 20 μL of MTT solution (5 mg/mL), and the plates were incubated for another 4 h. Then, 100 μL of dissolving solution (containing 5% isopropanol, 10% sodium dodecyl sulfate, and 0.1% HCl, dissolved in water) was added to dissolve the formazan. The optical density was measured at 540 nm using a microplate reader (BioTeck Instruments, Vermont, US). The half inhibitory concentration (IC~50~) value of each compound was calculated using the Origin75 software.

3. Results and discussion {#sec3}
=========================

3.1. Structure identification {#sec3.1}
-----------------------------

Six new (**1**, **2**, **6**--**8**, and **10**) and four known (**3**--**5** and **9**) dammarane-type saponins were isolated. The four known saponins were identified as ginsenosides F~1~ (**3**) [@bib24], Rc (**4**) [@bib25], Re (**5**), and Rd (**9**) [@bib19].

Compound **1** was obtained as a white amorphous powder. \[*α*\]25 D+ 25.8° (*c* = 0.1, MeOH). Its molecular formula was determined as C~40~H~66~O~12~, evidenced by the High-Resolution-Electron Spray Ionization-Mass Spectra data (HR-ESI-MS) data (*m/z* 761.4446 \[M + Na\]^+^, calculated for C~40~H~66~O~12~Na, 761.4446). The absorption bands at 3321, 1651, and 1015 cm^−1^ due to hydroxyl, ester, and olefin groups, respectively, were shown in its IR spectrum. The acidic hydrolysis of **1** gained [d]{.smallcaps}-glucose. One anomeric proton (*δ* 5.10) in the ^1^H-NMR spectrum and one corresponding anomeric carbon were recorded at *δ* 98.0 in the ^13^C-NMR spectrum ([Table 1](#tbl1){ref-type="table"}). Furthermore, nine methyl singlets (*δ*~H~ 1.00, 1.03, 1.12, 1.47, 1.62, 1.67, 1.70, 2.00, and 3.67) were observed in the ^1^H-NMR spectrum, and *δ*~H~ 3.67 of which was protons bearing an oxygen function. Thirty carbon signals were assigned to the 20(*S*)-PPT sapogenin [@bib19], and a set of signals showed a *β*-[d]{.smallcaps}-glucosyl moiety in the ^13^C-NMR spectrum. Compared with **3** [@bib24], the presence of additional signals corresponding to two carbonyl carbons (*δ*~C~ 167.0 and 167.3), one methylene group \[*δ*~C~ 41.7/*δ*~H~ 3.72, 3.71 (each 1H, br s)\], and one methoxyl group \[*δ*~C~ 52.3/*δ*~H~ 3.67 (3H, s)\], along with the Heteronuclear Multiple Bond Correlation (HMBC) cross-peaks of *δ*~H~ 5.05, 4.68/*δ*~C~ 167.0, *δ*~H~ 3.71/*δ*~C~ 167.0, *δ*~H~ 3.71/*δ*~C~ 167.3 and *δ*~H~ 3.67/*δ*~C~ 167.3 ([Fig. 1](#fig1){ref-type="fig"}), as well as a downfield shift for C-6\' (*δ*~C~ 65.8) of the glucopyranosyl unit, revealed that there was a terminal methyl-esterified malonic acid group attached to C-6′ of glucopyranosyl moiety in **1** [@bib13], [@bib26], [@bib27]. On the basis of the aforementioned results, the structure of **1** was determined as 3*β*,6*α*,12*β*,20(*S*)-tetrahydroxy-dammar-24-ene-20-*O*-(6-*O*-malonyl methyl ester)-*β*-[d]{.smallcaps}-glucopyranoside and given the trivial name 6′-malonyl methyl ester ginsenoside F~1~.Table 1^1^H- and ^13^C-NMR data for Compounds **1** and **2** (C~5~D~5~N, 500 MHz)Table 1No.12*δ*~C~*δ*~H~*δ*~C~*δ*~H~139.41.01 (1H, m), 1.72 (1H, m)38.90.91(1H, m), 1.59 (1H, m)228.21.87 (2H, m)23.91.71(2H, m)378.63.54 (1H, dd, 10.5, 6.5)81.34.76 (1H, t, 9.0)440.4--39.2--561.81.22 (1H, d, 10.0)61.41.20 (1H, d, 10.0)667.84.42 (1H, m)67.44.35 (1H, d, 11.5)747.51.88 (1H, m), 1.96 (1H, m)47.31.86 (1H, m), 1.93 (1H, m)841.3--41.2--950.01.57 (1H, m)49.71.50 (1H, m)1039.4--38.6--1130.81.61 (1H, m), 2.09 (1H, m),30.81.62 (1H, m), 2.02 (1H, m)1270.24.18 (1H, m)70.34.13 (1H, m)1349.22.02 (1H, m)49.11.98 (1H, m)1451.4--51.4--1531.01.06 (1H, m), 1.55 (1H, m)30.90.91 (1H, m), 1.58 (1H, m)1626.71.38 (1H, m), 1.86 (1H, m)26.71.35 (1H, m), 1.84 (1H, m)1751.62.58 (1H, m)51.82.53 (1H, m)1817.71.12 (3H, s)17.61.07 (3H, s)1917.51.03 (3H, s)17.40.98 (3H, s)2083.5--83.4--2122.11.62 (3H, s)22.51.63 (3H, s)2236.21.84 (1H, m), 2.32 (1H, m)36.11.82 (1H, m), 2.40 (1H, m)2323.02.29 (1H, m), 2.54 (1H, m)23.42.26 (1H, m), 2.50 (1H, m)24126.15.35 (1H, t, 6.4)126.05.28 (1H, m)25131.1--131.1--2625.81.70 (3H, s)25.81.62 (3H, s)2717.81.67 (3H, s)17.91.60 (3H, s)2832.02.00 (3H, s)31.41.65 (3H, s)2916.51.47 (3H, s)17.01.33 (3H, s)3017.51.00 (3H, s)17.40.95 (3H, s)1′98.05.10 (1H, d, 8.0)98.45.19 (1H, d, 7.5)2′75.03.96 (1H, m)75.34.02 (1H, t, 8.0)3′79.24.17 (1H, m)79.34.27 (1H, t, 9.0)4′71.53.92 (1H, m)71.64.21 (1H, t, 9.0)5′74.83.94 (1H, m)78.33.94 (1H, m)6′65.84.68 (1H, dd, 11.5, 7.0)\
5.05 (1H, br d, 11.5)62.94.33 (1H, br d, 11.5)\
4.50 (1H, dd, 11.5, 2.0)1″167.0--170.9--2″41.73.71 (1H, br s), 3.72 (1H, br s)21.32.11 (3H, s)3″167.3--4″52.33.67 (3H, s)Fig. 1Chemical structures and HMBC (H![](fx1.gif)C) correlations of Compounds 1, 2, 6--8, and 10. The red part of each structure shows its novelty, and the key HMBC correlations are shown by blue arrows.HMBC, heteronuclear multiple bond correlation.Fig. 1

Compound **2** was isolated as a white amorphous powder with a molecular formula C~38~H~64~O~10~ determined by HR-ESI-MS (*m/z* 703.4343 \[M + Na\]^+^, calcd for C~38~H~64~O~10~Na, 703.4391). \[*α*\]25 D+ 28.4° (*c* = 0.1, MeOH). Its IR spectrum showed strong absorption bands at 3324 and 1012 cm^−1^, suggesting an oligoglycosidic structure, together with absorption band at 1649 cm^−1^ due to carbonyl group. The acid hydrolysis of **2** liberated [d]{.smallcaps}-glucose. The ^1^H- and ^13^C-NMR spectra ([Table 1](#tbl1){ref-type="table"}) of **2** were very similar to those of **3** [@bib24], except for the signals due to an acetoxyl group at *δ*~C~ 21.3 and 170.9 and *δ*~H~ 2.11 (3H, s), which suggested that **2** was an acetyl derivative of **3** ([Fig. 1](#fig1){ref-type="fig"}). The acetoxyl group was confirmed at C-3 position of aglycone moiety on the basis of an acetylation shift effect on C-3 around *δ*~C~ 81.3 and HMBC cross-peaks of H-3 \[*δ*~H~ 4.76 (1H, t, *J* = 9.0 Hz)\] to carbonyl carbon at *δ*~C~ 170.9 and H-2″ \[*δ*~H~ 2.11 (3H, s)\] to C-3 (*δ*~C~ 81.3). Thus, the structure of **2** was determined as 6*α*,12*β*,20(*S*)-trihydroxy-3*β-*acetoxyl*-*dammar-24-ene-20-*O*-*β*-[d]{.smallcaps}-glucopyranoside and named as 3*β-*acetoxyl ginsenoside F~1~.

Compound **6** was isolated as a white amorphous powder with a molecular formula C~47~H~80~O~17~ determined by HR-ESI-MS spectrum (*m/z* 939.5289 (\[M + Na\]^+^, calcd for C~47~H~80~O~17~Na, 939.5293)). \[*α*\]25 D--6.2° (*c* = 0.1, MeOH). Its IR spectrum showed absorption bands due to hydroxyl and olefin groups at 3412 and 1630 cm^−1^. The ^1^H-NMR spectrum of **6** ([Table 2](#tbl2){ref-type="table"}) displayed eight methyl singlets \[*δ*~H~ 0.99, 1.10, 1.18, 1.36, 1.61, 1.62 (6H), and 2.01\], a methyl doublet \[*δ*~H~ 1.77 (3H, d, *J* = 6.2 Hz)\], an olefinic \[*δ*~H~ 5.26 (1H, t, *J* = 7.5 Hz)\], and three anomeric \[*δ*~H~ 6.26 (1H, br s), 5.32 (1H, d, *J* = 5.0 Hz), 5.20 (1H, d, *J* = 8.0 Hz)\]. In the ^13^C-NMR spectrum of **6**, thirty carbon signals assigned to the aglycone and three sets of signals due to one *β*-glucopyranosyl, one *α*-arabinopyranosyl, and one *α-*rhamnopyranosyl groups were observed. The result of acidic hydrolysis of **6** was consistent with the ^13^C-NMR findings of sugar moiety type. Comparison of the ^13^C-NMR chemical shifts of the aglycone moiety in **6** with those of 20(*S*)-protopanaxatriol and its glycosides [@bib19] suggested that **6** ([Fig. 1](#fig1){ref-type="fig"}) was a 20(*S*)-PPT ginsenoside, which was confirmed by HMBC analysis. Furthermore, the HMBC correlation between anomeric proton of rhamnosyl *δ*~H~ 6.26 (1H, br s) and *δ*~C~ 77.8 of C-2′ arabinosyl showed that there was a sugar sequence of *α*-~L~-rhamnopyranosyl-(1→2)-*α*-~L~-arabinopyranosyl in **6**. The ^1^H- and ^13^C-NMR data of the sugar moiety were identical to the reported data [@bib28], [@bib29]. The linkage sites of the sugars and the aglycone were determined by HMBC correlations of H-1′ \[*δ*~H~ 5.32 (1H, d, *J* = 5.0 Hz)\] to C-6 (*δ*~C~ 75.8) and H-1‴ \[*δ*~H~ 5.20 (1H, d, *J* = 8.0 Hz)\] to C-20 (*δ*~C~ 83.3). Accordingly, the structure of **6** was determined as 6-*O*- \[*α*-~L~-rhamnopyranosyl-(1→2)-*α*-~L~-arabinopyranosyl\]-3*β*,6*α*,12*β*,20(*S*)- tetrahydroxy-dammar-24-ene-20-*O*-*β*-[d]{.smallcaps}-glucopyranoside and given the trivial name ginsenoside Rh~24~ [@bib30]. So far as we know, the sugars and their the sequence located at C-6 resulted in a new type of sugar chain among all the known ginsenosides in *Panax* genus plants [@bib6], [@bib7].Table 2^1^H- and ^13^C-NMR data for Compounds **6** and **7** (C~5~D~5~N, 500 MHz)Table 2No.67*δ*~C~*δ*~H~*δ*~C~*δ*~H~139.40.97 (1H, m), 1.72 (1H, m)39.30.76 (1H, m), 1.57 (1H, m)227.81.81 (1H, m), 1.87 (1H, m)26.71.37 (1H, m), 1.85 (1H, m)378.43.45 (1H, m)89.13.30 (1H, dd, 12.5, 5.0)439.9--39.8--560.91.41 (1H, d, 11.0)56.50.71 (1H, d, 11.0)675.84.53 (1H, m)18.51.41 (1H, m), 1.55 (1H, m)745.72.01 (1H, m)\
2.18 (1H, dd, 12.0, 3.0)35.21.21 (1H, m), 1.49 (1H, m)841.2--40.1--949.61.55 (1H, m)50.31.40 (1H, m)1039.6--37.0--1131.01.55 (1H, m), 2.09 (1H, m)30.91.50 (1H, m), 1.99 (1H, m)1270.24.17 (1H, m)70.34.15 (1H, m)1349.22.07 (1H, m)49.52.01 (1H, t, 11.0)1451.4--51.5--1530.81.02 (1H, m), 1.61 (1H, m)30.81.01 (1H, m), 1.58 (1H, m)1626.71.36 (1H, m), 1.84 (1H, m)26.91.37 (1H, m), 1.85 (1H, m)1751.62.56 (1H, m)51.72.56 (1H, m)1817.61.18 (3H, s)16.00.98 (3H, s)1917.30.99 (3H, s)16.30.84 (3H, s)2083.3--83.4--2122.31.62 (3H, s)22.41.65 (3H, s)2236.21.85 (1H, m), 2.39 (1H, m)36.21.85 (1H, m), 2.38 (1H, m)2323.22.25 (1H, m), 2.50 (1H, m)23.22.38 (1H, m), 2.57 (1H, m)24126.05.26 (1H, t, 7.5)126.15.32 (1H, t, 7.0)25130.9--131.0--2625.81.61 (3H, s)25.81.63 (3H, s)2717.81.62 (3H, s)17.91.68 (3H, s)2832.12.01 (3H, s)27.81.31 (3H, s)2917.41.36 (3H, s)16.31.12 (3H, s)3017.51.00 (3H, s)17.40.97 (3H, s)1′102.85.32 (1H, d, 5.0)105.14.93 (1H, d, 7.5)2′77.84.42 (1H, m)84.14.16 (1H, m)3′75.94.33 (1H, m)78.54.31 (1H, m)4′70.84.22 (1H, m)71.74.16 (1H, m)5′66.03.83 (1H, dd, 11.4, 8.2)\
4.50 (1H, m)78.23.93 (1H, dd, 11.4, 8.2)6′63.04.33 (1H, m)\
4.57 (1H, br d, 11.5)1″101.66.26 (1H, br s)107.05.27 (1H, d, 7.0)2″72.44.74 (1H, m)76.64.13 (1H, m)3″72.44.62 (1H, dd, 9.0, 3.0)78.24.16 (1H, m)4″74.14.33 (1H, m)71.24.24 (1H, m)5″69.84.78 (1H, m)67.63.73 (1H, t, 11.0)\
4.41 (1H, dd, 11.0, 5.0)6″18.81.77 (3H, d, 6.2)1‴98.35.20 (1H, d, 8.0)98.25.15 (1H, d, 8.0)2‴75.24.01 (1H, t, 8.0)75.13.98 (1H, m)3‴79.34.25 (1H, m)79.34.18 (1H, m)4‴71.74.14 (1H, m)72.23.99 (1H, m)5‴78.33.94 (1H, m)76.64.04 (1H, m)6‴63.04.34 (1H, m), 4.50 (1H, m)68.54.11 (1H, m)\
4.67 (1H, dd, 11.0, 2.5)1′′′′110.25.66 (1H, br s)2′′′′83.34.87 (1H, m)3′′′′78.94.80 (1H, m)4′′′′86.14.75 (1H, m)5′′′′62.74.22 (1H, m), 4.49 (1H, m)

Compound **7** was isolated as a white amorphous powder with a molecular formula C~52~H~88~O~21~ determined by HR-ESI-MS (*m/z* 1071.5707 \[M + Na\]^+^, calcd for C~52~H~88~O~21~Na, 1071.5716). \[*α*\]25 D+ 48.2° (*c* = 0.1, MeOH). Its IR spectrum showed absorption bands due to hydroxyl and olefin groups at 3389 and 1646 cm^−1^. The ^13^C-NMR spectrum gave 52 carbon signals, of which 22 were assigned to the sugar moiety and 30 to the 20(*S*)-PPD sapogenin [@bib19]. The acidic hydrolysis of **7** obtained [d]{.smallcaps}-glucose, [d]{.smallcaps}-xylose, and ~L~-arabinose. The ^1^H- and ^13^C-NMR data ([Table 2](#tbl2){ref-type="table"}) of **7** were very similar to those of **4** [@bib25], except for a xylosyl instead of a glucosyl at C-2′. The xylosyl group at C-2′ was further confirmed by the correlation observed between anomeric proton of xylosyl *δ*~H~ 5.27 (1H, d, *J* = 7.0 Hz) and *δ*~C~ 84.1 of C-2′ glucosyl that linked at C-3 of the aglycone in the HMBC experiment ([Fig. 1](#fig1){ref-type="fig"}). Thus, the structure of **7** was determined as 3-*O*-\[*β*-[d]{.smallcaps}-xylopyranoyl-(1→2)-*β*-[d]{.smallcaps}-glucopyranoyl\]- 3*β*,12*β*,20(*S*)- trihydroxy-dammar-24-ene-20-*O*-*α*-~L~-arabinofuranosyl-(1→6)-*β*-[d]{.smallcaps}- glucopyranoside and given the trivial name ginsenoside Rh~25~.

Compound **8** was obtained as a white amorphous powder. It exhibited the molecular formula C~48~H~82~O~19~ according to the HR-ESI-MS data (*m/z* 985.5349 \[M + Na\]^+^, calcd for C~48~H~82~O~19~Na, 985.5348). \[*α*\]25 D+ 51.5° (*c* = 0.1, MeOH). Its IR spectrum showed absorption bands due to hydroxyl and olefin groups at 3397 and 1604 cm^−1^. Glucose was identified in the acid hydrolysates. Comparison of the ^1^H- and ^13^C-NMR data of **8** ([Table 3](#tbl3){ref-type="table"}) with those of **9** [@bib19] revealed that some different signals due to the B-ring part of the sapogenin moiety was due to the presence of a hydroxyl group signals at *δ*~H~ 4.02/*δ*~C~ 74.6. The long-range correlations between H-5 \[*δ*~H~ 0.84 (1H, br d, *J* = 12.5Hz)\], H-6 \[1.75 (1H, m), 1.93 (1H, m)\], H-18 \[*δ*~H~ 1.26 (3H, s)\], and *δ*~C~ 74.6 in the HMBC experiment ([Fig. 1](#fig1){ref-type="fig"}), as well as signals for C-6 and C-7, were shifted to lower field at *δ*~C~ 29.2 and *δ*~C~ 74.6 compared to those of **9** [@bib19], indicating that the original methylene at C-7 was transformed to a hydroxyl group. In the rotating frame overhause effect spectroscopy (ROESY) experiment, rotating frame overhause effect (ROE) correlations were observed between H-7 \[*δ*~H~ 4.02 (1H, m)\], H-9 \[*δ*~H~ 1.39 (1H, m)\], and H-7 and H-30 \[*δ*~H~ 1.17 (3H, s)\] ([Fig. 2](#fig2){ref-type="fig"}). Thus, the hydroxyl at C-7 was *β* configuration*.* Consequently, the structure of **8** was determined as 3-*O*-\[*β*-[d]{.smallcaps}- glucopyranoyl-(1→2)-*β*-[d]{.smallcaps}-glucopyranoyl\]-3*β*,7*β*,12*β*,20(*S*)-tetrahydroxy-dammar-24-ene-20-*O*-*β*-[d]{.smallcaps}-glucopyranoside and given the trivial name 7*β*-hydroxyl ginsenoside Rd.Table 3^1^H- and ^13^C-NMR data for Compounds **8** and **10** (C~5~D~5~N, 500 MHz)Table 3No.810*δ*~C~*δ*~H~*δ*~C~*δ*~H~139.20.74 (1H, m), 1.56 (1H, m)39.20.76 (1H, m), 1.58 (1H, m)226.91.84 (1H, m), 2.23 (1H, m)26.81.87 (1H, m), 2.22 (1H, m)388.93.30 (1H, dd, 12.0, 4.5)89.03.30 (1H, dd, 11.5, 4.0)439.6--39.7--554.10.84 (1H, d, 12.5)56.40.69 (1H, d, 11.5)629.21.75 (1H, m), 1.93 (1H, m)18.51.40 (1H, m), 1.51 (1H, m)774.64.02 (1H, m)35.21.23 (1H, m), 1.49 (1H, m)845.9--40.1--950.01.39 (1H, m)50.21.40 (1H, m)1037.0--36.9--1131.01.64 (1H, m), 2.03 (1H, m)30.71.50 (1H, m), 1.98 (1H, m)1270.24.15 (1H, m)70.14.20 (1H, m)1350.52.07 (1H, m)49.62.01 (1H, m)1451.6--51.5--1534.51.77 (1H, m), 2.15 (1H, m)31.01.03 (1H, m), 1.58 (1H, m)1627.21.46 (1H, m), 1.94 (1H, m)26.71.39 (1H, m), 1.87 (1H, m)1750.92.60 (1H, m)51.62.61 (1H, m)1810.71.26 (3H, s)16.00.96 (3H, s)1916.50.88 (3H, s)16.30.84 (3H, s)2083.6--83.5--2122.41.66 (3H, s)22.01.62 (3H, s)2236.31.90 (1H, m), 2.45 (1H, m)36.11.81 (1H, m), 2.41 (1H, m)2323.22.28 (1H, m), 2.52 (1H, m)23.02.31 (1H, m), 2.58 (1H, m)24126.05.27 (1H, t, 7.0)126.15.30 (1H, t, 7.5)25131.9--130.9--2625.81.61 (3H, s)25.81.66 (3H, s)2717.81.62 (3H, s)17.81.66 (3H, s)2828.11.29 (3H, s)28.11.31 (3H, s)2916.81.13 (3H, s)16.61.14 (3H, s)3017.41.17 (3H, s)17.51.00 (3H, s)1′105.14.93 (1H, d, 7.5)105.14.93 (1H, d, 7.5)2′83.64.24 (1H, m)83.64.25 (1H, m)3′78.04.25 (1H, m)78.04.26 (1H, m)4′71.74.14 (1H, m)71.74.16 (1H, m)5′78.34.32 (1H, m)75.04.02 (1H, m)6′62.94.36 (1H, m)\
4.58 (1H, br d, 11.5)64.44.75 (1H, dd, 11.5, 7.0)\
5.05 (1H, dd, 11.5, 2.0)1″106.25.37 (1H, d, 7.5)106.15.38 (1H, d, 7.5)2″77.24.13 (1H, m)77.24.14 (1H, m)3″78.23.94 (1H, m)78.13.94 (1H, m)4″71.74.33 (1H, m)71.73.99 (1H, m)5″78.13.94 (1H, m)78.33.94 (1H, m)6″62.94.36 (1H, m)\
4.52 (1H, dd, 11.5, 2.5)62.94.36 (1H, m)\
4.58 (1H, dd, 12.0, 2.0)1‴98.35.23 (1H, d, 7.5)98.15.14 (1H, d, 7.5)2‴75.24.04 (1H, t, 8.5)75.04.02 (1H, m)3‴79.34.26 (1H, m)79.24.21 (1H, m)4‴71.74.14 (1H, m)71.74.16 (1H, m)5‴78.33.95 (1H, m)78.43.94 (1H, m)6‴62.74.36 (1H, m), 4.46 (1H, m)62.84.43 (1H, m), 4.50 (1H, m)1′′′′166.4--2′′′′123.25.99 (1H, dt, 15.5, 1.5)3′′′′144.87.07 (1H, dq, 15.5, 6.9)4′′′′17.71.68 (3H, dd, 7.0, 1.5)Fig. 2Selected key ROESY correlations of the sapogenin of Compound **8**.Fig. 2

Compound **10** was obtained as a white amorphous powder. It possessed the molecular formula C~52~H~86~O~19~, which was determined by the HR-ESI-MS data (*m/z* 1037.5646 \[M + Na\]^+^, calcd for C~52~H~86~O~19~Na, 1037.5661). \[*α*\]25 D+ 40.4° (*c* = 0.1, MeOH). The IR spectrum of **10** showed absorption bands at 1728 and 1655 cm^−1^ ascribed to an *α*,*β*-unsaturated ester and olefin and strong absorption bands at 3337 and 1073 cm^−1^ suggestive of an oligoglycosidic structure. Glucose was identified in the acid hydrolyzates. The ^1^H- and ^13^C-NMR data ([Table 3](#tbl3){ref-type="table"}) of **10** were very similar to those of **9** [@bib19], except for the additional signals, i.e., a methyl group *δ*~C~ 17.7/*δ*~H~ 1.68, a double bond *δ*~C~ 144.8, 123.2/*δ*~H~ 7.07, 5.99, and a carbonyl carbon *δ*~C~ 166.4. Further analysis confirmed that these signals were assigned to a crotonic group. Based on the typical *AB*-system coupling constant (*J* = 15.5 Hz) of *δ*~H~ 7.07 and *δ*~H~ 5.99, the configuration of the crotonic unit was determined as (*E*). By comparing the ^13^C-NMR data with those of **9** [@bib19], the terminal C-6′ resonance was deshielded, whereas that of C-5′ was shielded. The malonylation site at 6′-OH was confirmed by the HMBC cross-peaks of H-6′ \[*δ*~H~ 4.75 (1H, dd, *J* = 11.5, 7.0 Hz) and *δ*~H~ 5.05 (1H, dd, *J* = 11.5, 2.0 Hz)\] to the carbonyl carbon at *δ*~C~ 166.4 ([Fig. 1](#fig1){ref-type="fig"}). The structure of **10** was thus defined as 3-*O*-{6-*O*-\[(*E*)-but-2-enoyl\]-*β*-[d]{.smallcaps}-glucopyranoyl-(1→2)-*β*-[d]{.smallcaps}-glucopyranoyl}-3*β*,12*β*, 20(*S*)-trihydroxy-dammar-24-ene-20-*O*-*β*-[d]{.smallcaps}-glucopyranoside and given the trivial name ginsenoside Rh~26~. Its analogs with C-6″ crotonyl group have been isolated from the roots of *P. ginseng* and *P. quinquefolium* [@bib26], [@bib31]. To the best of our knowledge, **10** that possesses crotonyl group is the first ginsenoside isolated from *P. ginseng* flower buds.

3.2. MTT assay {#sec3.2}
--------------

Ginsenosides have attracted increasing interest because of its promotion of tumor apoptosis and prevention of tumor invasion and metastasis [@bib32], [@bib33], [@bib34]. To find more potent antitumor agents from *P. ginseng* flower buds, in this study, we evaluate the antitumor activity of the isolated compounds against three human cancer cell lines including human leukemia cell line HL-60, human gastric cancer cell line MGC80-3, and human hepatoma cell line Hep-G2 in an MTT assay, using vinorelbine as a positive control.

As can be seen from the data expressed in the IC~50~ values in [Table 4](#tbl4){ref-type="table"}, Compound **7** did not affect the cell proliferation of all the three cell lines even at the highest test concentration of 200 μM, whereas the other new compounds displayed antiproliferative activity at wide different concentrations. The direct substitution of malonyl or acetyl at C-6′ or C-3 position to Compounds **1**, **10,** or **2** could increase the antiproliferative activity, by comparing Compounds **1** and **2** with **3**, **9** and **10**. The IC~50~ value of Compound **1** was about threefold to fourfold higher than that of Compound **3** on the three cell lines, whereas Compound **10** showed minor cytotoxicity. Additional 7*β*-hydroxyl at C-7 position did not significantly increase antiproliferative potency, as shown in Compounds **8** and **9**. Comparing with Compounds **1**--**3** with one sugar moiety, the antiproliferative effects of Compounds **4**--**10** with 3 or 4 sugar moieties were increased with the decreasing number of sugar moieties in a ginsenoside molecule, which was consistent with the literature [@bib1]. And, the changes in the sugar type of the sugar moieties had a slight effect on the antitumor activity, which can be seen between Compounds **4** and **7** and between **5** and **6**.Table 4Cytotoxicity of Compounds **1**−**10** against three human cancer cell lines (IC~50~, μM)Table 4CompoundsHL-60MGC80-3Hep-G2**1**16.74 ± 2.6529.51 ± 0.8220.48 ± 1.83**2**58.31 ± 3.3242.18 ± 2.4925.62 ± 0.87**3**65.36 ± 1.3587.58 ± 1.7682.14 ± 3.88**4**\>200\>200\>200**5**\>200\>200\>200**6**174.12 ± 1.93168.14 ± 3.36\>200**7**\>200\>200\>200**8**122.63 ± 2.46158.83 ± 2.05\>200**9**\>200\>200\>200**10**105.51 ± 4.8482.37 ± 4.58156.74 ± 2.61Vinorelbine9.36 ± 2.7725.24 ± 3.1818.86 ± 1.19[^1][^2]
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[^1]: Data were expressed as mean ± SD (*n* = 3). Vinorelbine was used as a positive drug.

[^2]: IC~50~, half inhibitory concentration; SD, standard deviation.
